Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
JAMA Neurology
|
May 19, 2025
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease
Alexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease
Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 13, 2022
[<sup>18</sup>F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
Alexander F Santillo, Antoine Leuzy, Michael Honer, et al.
Nature Medicine
|
March 4, 2020
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Alexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 27, 2021
A multicenter comparison of [<sup>18</sup>F]flortaucipir, [<sup>18</sup>F]RO948, and [<sup>18</sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
Antoine Leuzy, Tharick A Pascoal, Olof Strandberg, et al.
JAMA Neurology
|
December 4, 2023
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies
Niklas Mattsson-Carlgren, Lyduine E Collij, Erik Stomrud, et al.
Science Advances
|
May 20, 2020
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
Niklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
JAMA Neurology
|
December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
JAMA Neurology
|
May 19, 2025
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease
Alexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease
Anika Wuestefeld, Alexa Pichet Binette, Danielle van Westen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 13, 2022
[<sup>18</sup>F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
Alexander F Santillo, Antoine Leuzy, Michael Honer, et al.
Nature Medicine
|
March 4, 2020
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 24, 2025
Biomarkers
Alexa Pichet Binette, Ruben Smith, Gemma Salvadó, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 27, 2021
A multicenter comparison of [<sup>18</sup>F]flortaucipir, [<sup>18</sup>F]RO948, and [<sup>18</sup>F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
Antoine Leuzy, Tharick A Pascoal, Olof Strandberg, et al.
JAMA Neurology
|
December 4, 2023
Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies
Niklas Mattsson-Carlgren, Lyduine E Collij, Erik Stomrud, et al.
Science Advances
|
May 20, 2020
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
Niklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, et al.
JAMA
|
July 28, 2024
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al.
JAMA Neurology
|
December 20, 2021
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas C Cullen, et al.
Page
of 14